FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:295-303 January 23, 2003 Number 4 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background The influence of left ventricular outflow tract obstruction on the clinical outcome of hypertrophic cardiomyopathy remains unresolved.

Methods We assessed the effect of outflow tract obstruction on morbidity and mortality in a large cohort of patients with hypertrophic cardiomyopathy who were followed for a mean (±SD) of 6.3±6.2 years.

Results Of the 1101 consecutive patients, 273 (25 percent) had obstruction of left ventricular outflow under basal (resting) conditions with a peak instantaneous gradient of at least 30 mm Hg. A total of 127 patients (12 percent) died of hypertrophic cardiomyopathy, and 216 surviving patients (20 percent) had severe, disabling symptoms of progressive heart failure (New York Heart Association [NYHA] functional class III or IV). The overall probability of death related to hypertrophic cardiomyopathy was significantly greater among patients with outflow tract obstruction than among those without obstruction (relative risk, 2.0; P=0.001). The risk of progression to NYHA class III or IV or death specifically from heart failure or stroke was also greater among patients with obstruction (relative risk, 4.4; P<0.001), particularly among patients 40 years of age or older (P<0.001). Age-adjusted multivariate analysis confirmed that outflow tract obstruction was independently associated with an increased risk of both death related to hypertrophic cardiomyopathy (relative risk, 1.6; P=0.02) and progression to NYHA class III or IV or death from heart failure or stroke (relative risk, 2.7; P<0.001). The likelihood of severe symptoms and death related to outflow tract obstruction did not increase as the gradient increased above the threshold of 30 mm Hg.

Conclusions In patients with hypertrophic cardiomyopathy, left ventricular outflow tract obstruction at rest is a strong, independent predictor of progression to severe symptoms of heart failure and of death.

Source Information

From the Division of Cardiology, Tufts–New England Medical Center, Boston (M.S.M.); the Regional Referral Center for Myocardial Diseases, Azienda Ospedaliera Careggi, Florence, Italy (I.O., F.C.); the Department of Clinical Medicine, Cardiovascular and Immunological Sciences, Federico II University of Naples, Naples, Italy (S.B., M.A.L.); and the Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis (S.A.C., J.R.L., B.J.M.).

Address reprint requests to Dr. Barry Maron at the Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 E. 28th St., Suite 60, Minneapolis, MN 55407, or at hcm.maron{at}mhif.org.

Full Text of this Article

Related Letters:

Hypertrophic Cardiomyopathy and Outflow Tract Obstruction
Monserrat L., Penas-Lado M., Castro-Beiras A., Iqbal K., Tramboo N. A., Mohi-Ud-Din K., Spevack D. M., Maron M. S., Olivotto I., Maron B. J.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:1815-1816, May 1, 2003. Correspondence

This article has been cited by other articles:

• Sorajja, P., Valeti, U., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., Hodge, D. O., Schaff, H. V., Holmes, D. R. Jr (2008). Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy. Circulation 118: 131-139 [Abstract] [Full Text]  
• Saumarez, R. C., Pytkowski, M., Sterlinski, M., Bourke, J. P., Clague, J. R., Cobbe, S. M., Connelly, D. T., Griffith, M. J., McKeown, P. P., McLeod, K., Morgan, J. M., Sadoul, N., Chojnowska, L., Huang, C. L.-H., Grace, A. A. (2008). Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J 29: 1653-1661 [Abstract] [Full Text]  
• Pinamonti, B., Di Lenarda, A., Nucifora, G., Gregori, D., Perkan, A., Sinagra, G. (2008). Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study. Eur J Echocardiogr 9: 466-471 [Abstract] [Full Text]  
• Elliott, P. (2008). Relevance of platelet activation in obstructive hypertrophic cardiomyopathy. Heart 94: 688-689 [Full Text]  
• Dimitrow, P P, Undas, A, Bober, M, Tracz, W, Dubiel, J S (2008). Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart 94: e21-e21 [Abstract] [Full Text]  
• Mittnacht, A. J., Fanshawe, M., Konstadt, S. (2008). Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery. SEMIN CARDIOTHORAC VASC ANESTH 12: 33-59 [Abstract]  
• Bayrak, F., Kahveci, G., Mutlu, B., Sonmez, K., Degertekin, M. (2008). Tissue Doppler imaging to predict clinical course of patients with hypertrophic cardiomyopathy. Eur J Echocardiogr 9: 278-283 [Abstract] [Full Text]  
• Revera, M., van der Merwe, L., Heradien, M., Goosen, A., Corfield, V. A., Brink, P. A., Moolman-Smook, J. C. (2008). Troponin T and {beta}-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy. Cardiovasc Res 77: 687-694 [Abstract] [Full Text]  
• Hansen, M. W., Merchant, N. (2007). MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances. Am. J. Roentgenol. 189: 1335-1343 [Abstract] [Full Text]  
• McLeod, C. J., Ommen, S. R., Ackerman, M. J., Weivoda, P. L., Shen, W. K., Dearani, J. A., Schaff, H. V., Tajik, A. J., Gersh, B. J. (2007). Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 28: 2583-2588 [Abstract] [Full Text]  
• Olivotto, I., Ommen, S. R., Maron, M. S., Cecchi, F., Maron, B. J. (2007). Surgical Myectomy Versus Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: Will There Ever Be a Randomized Trial?. J Am Coll Cardiol 50: 831-834 [Abstract] [Full Text]  
• Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., Boriani, G., Estes, N. A. M. III, Favale, S., Piccininno, M., Winters, S. L., Santini, M., Betocchi, S., Arribas, F., Sherrid, M. V., Buja, G., Semsarian, C., Bruzzi, P. (2007). Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JAMA 298: 405-412 [Abstract] [Full Text]  
• Maron, B. J. (2007). Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. Circulation 116: 196-206 [Full Text]  
• Fifer, M. A. (2007). Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy. Circulation 116: 207-216 [Full Text]  
• Petersen, S. E., Jerosch-Herold, M., Hudsmith, L. E., Robson, M. D., Francis, J. M., Doll, H. A., Selvanayagam, J. B., Neubauer, S., Watkins, H. (2007). Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging. Circulation 115: 2418-2425 [Abstract] [Full Text]  
• Barac, I., Upadya, S., Pilchik, R., Winson, G., Passick, M., Chaudhry, F. A., Sherrid, M. V. (2007). Effect of Obstruction on Longitudinal Left Ventricular Shortening in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 49: 1203-1211 [Abstract] [Full Text]  
• Nagueh, S. F., Mahmarian, J. J. (2006). Noninvasive Cardiac Imaging in Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol 48: 2410-2422 [Abstract] [Full Text]  
• Maron, B. J., Olivotto, I., Maron, M. S. (2006). Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: reply. Eur Heart J 27: 3073-3074 [Full Text]  
• Nishimura, R. A., Ommen, S. R. (2006). Hypertrophic Cardiomyopathy: The Search for Obstruction. Circulation 114: 2200-2202 [Full Text]  
• Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., Maron, B. J. (2006). Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Circulation 114: 2232-2239 [Abstract] [Full Text]  
• Knight, C. J (2006). Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.. Heart 92: 1339-1344 [Full Text]  
• Elliott, P. M., Gimeno, J. R., Tome, M. T., Shah, J., Ward, D., Thaman, R., Mogensen, J., McKenna, W. J. (2006). Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27: 1933-1941 [Abstract] [Full Text]  
• Maron, B. J., Olivotto, I., Maron, M. S. (2006). The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?. Eur Heart J 27: 1895-1897 [Full Text]  
• Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey-Bojack, S., Manning, W. J., Udelson, J. E., Maron, B. J. (2006). Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy. Circulation 114: 216-225 [Abstract] [Full Text]  
• Spirito, P., Autore, C. (2006). Management of hypertrophic cardiomyopathy.. BMJ 332: 1251-1255 [Full Text]  
• Olivotto, I., Cecchi, F., Gistri, R., Lorenzoni, R., Chiriatti, G., Girolami, F., Torricelli, F., Camici, P. G. (2006). Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 47: 1043-1048 [Abstract] [Full Text]  
• Kasikcioglu, E. (2006). The role of echocardiography screening in athletes for cardiovascular disease. Eur J Echocardiogr 7: 182-183 [Full Text]  
• Kido, S., Hasebe, N., Ishii, Y., Kikuchi, K. (2006). Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion of ANP, not BNP, in hypertrophic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 290: H1064-H1070 [Abstract] [Full Text]  
• Minakata, K., Dearani, J. A., O'Leary, P. W., Danielson, G. K. (2005). Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in Pediatric Patients: Early and Late Results. Ann. Thorac. Surg. 80: 1424-1430 [Abstract] [Full Text]  
• Nugent, A. W., Daubeney, P. E.F., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C.W., Weintraub, R. G., for the National Australian Childhood Cardiomyopat, (2005). Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study. Circulation 112: 1332-1338 [Abstract] [Full Text]  
• Rickers, C., Wilke, N. M., Jerosch-Herold, M., Casey, S. A., Panse, P., Panse, N., Weil, J., Zenovich, A. G., Maron, B. J. (2005). Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy. Circulation 112: 855-861 [Abstract] [Full Text]  
• Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., Schaff, H. V., Danielson, G. K., Tajik, A. J., Nishimura, R. A. (2005). Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol 46: 470-476 [Abstract] [Full Text]  
• Watkins, H., McKenna, W. J. (2005). The Prognostic Impact of Septal Myectomy in Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol 46: 477-479 [Full Text]  
• Olivotto, I., Maron, M. S., Adabag, A. S., Casey, S. A., Vargiu, D., Link, M. S., Udelson, J. E., Cecchi, F., Maron, B. J. (2005). Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy. J Am Coll Cardiol 46: 480-487 [Abstract] [Full Text]  
• Yacoub, M. H. (2005). Surgical Versus Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: The Pendulum Swings. Circulation 112: 450-452 [Full Text]  
• Roberts, R., Sigwart, U. (2005). Current Concepts of the Pathogenesis and Treatment of Hypertrophic Cardiomyopathy. Circulation 112: 293-296 [Full Text]  
• Balaram, S. K., Sherrid, M. V., Derose, J. J. Jr., Hillel, Z., Winson, G., Swistel, D. G. (2005). Beyond Extended Myectomy for Hypertrophic Cardiomyopathy: The Resection-Plication-Release (RPR) Repair. Ann. Thorac. Surg. 80: 217-223 [Abstract] [Full Text]  
• Konstadt, S. (2005). Anesthesia for non-cardiac surgery in the patient with cardiac disease. Canadian J. Anesthesia 52: R7-R7 [Full Text]  
• Maron, B. J. (2005). Surgery for Hypertrophic Obstructive Cardiomyopathy: Alive and Quite Well. Circulation 111: 2016-2018 [Full Text]  
• Woo, A., Williams, W. G., Choi, R., Wigle, E. D., Rozenblyum, E., Fedwick, K., Siu, S., Ralph-Edwards, A., Rakowski, H. (2005). Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy. Circulation 111: 2033-2041 [Abstract] [Full Text]  
• Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., Maron, B. J. (2005). Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 45: 1251-1258 [Abstract] [Full Text]  
• Autore, C., Bernabo, P., Barilla, C. S., Bruzzi, P., Spirito, P. (2005). The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45: 1076-1080 [Abstract] [Full Text]  
• Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., Maron, B. J. (2005). Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 45: 697-704 [Abstract] [Full Text]  
• Breithardt, O-A, Beer, G, Stolle, B, Lieder, F, Franke, A, Lawrenz, T, Hanrath, P, Kuhn, H (2005). Mid systolic septal deceleration in hypertrophic cardiomyopathy: clinical value and insights into the pathophysiology of outflow tract obstruction by tissue Doppler echocardiography. Heart 91: 379-380 [Full Text]  
• Ralph-Edwards, A., Woo, A., McCrindle, B. W., Shapero, J. L., Schwartz, L., Rakowski, H., Wigle, E. D., Williams, W. G. (2005). Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J. Thorac. Cardiovasc. Surg. 129: 351-358 [Abstract] [Full Text]  
• Kaufmann, P. A., Camici, P. G. (2005). Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications. JNM 46: 75-88 [Full Text]  
• Agarwal, S C, Purcell, I F, Furniss, S S (2005). Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation. Heart 91: e2-e2 [Abstract] [Full Text]  
• Deb, S. J., Schaff, H. V., Dearani, J. A., Nishimura, R. A., Ommen, S. R. (2004). Septal Myectomy Results in Regression of Left Ventricular Hypertrophy in Patients With Hypertrophic Obstructive Cardiomyopathy. Ann. Thorac. Surg. 78: 2118-2122 [Abstract] [Full Text]  
• Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Gersh, B. J., Nishimura, R. A. (2004). The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 2044-2053 [Abstract] [Full Text]  
• Boriani, G., Maron, B. J., Shen, W.-K., Spirito, P. (2004). Prevention of Sudden Death in Hypertrophic Cardiomyopathy: But Which Defibrillator for Which Patient?. Circulation 110: e438-e442 [Full Text]  
• Jorg-Ciopor, M., Namdar, M., Turina, J., Jenni, R., Schwitter, J., Turina, M., Hess, O. M., Kaufmann, P. A. (2004). Regional myocardial ischemia in hypertrophic cardiomyopathy: Impact of myectomy. J. Thorac. Cardiovasc. Surg. 128: 163-169 [Abstract] [Full Text]  
• Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., Deal, B. J., Driscoll, D. J., Estes, N.A. M. III, Araujo, C. G. S., Liang, D. H., Mitten, M. J., Myerburg, R. J., Pelliccia, A., Thompson, P. D., Towbin, J. A., Van Camp, S. P., for the Working Groups of the American Heart Assoc, (2004). Recommendations for Physical Activity and Recreational Sports Participation for Young Patients With Genetic Cardiovascular Diseases. Circulation 109: 2807-2816 [Abstract] [Full Text]  
• Wood, M. J, Picard, M. H (2004). Utility of echocardiography in the evaluation of individuals with cardiomyopathy. Heart 90: 707-712 [Full Text]  
• Frenneaux, M. P (2004). Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 90: 570-575 [Full Text]  
• McMahon, C. J., Nagueh, S. F., Pignatelli, R. H., Denfield, S. W., Dreyer, W. J., Price, J. F., Clunie, S., Bezold, L. I., Hays, A. L., Towbin, J. A., Eidem, B. W. (2004). Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy. Circulation 109: 1756-1762 [Abstract] [Full Text]  
• Maron, B. J., Tholakanahalli, V. N., Zenovich, A. G., Casey, S. A., Duprez, D., Aeppli, D. M., Cohn, J. N. (2004). Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy. Circulation 109: 984-989 [Abstract] [Full Text]  
• Chang, S. M., Lakkis, N. M., Franklin, J., Spencer, W. H. III, Nagueh, S. F. (2004). Predictors of Outcome After Alcohol Septal Ablation Therapy in Patients With Hypertrophic Obstructive Cardiomyopathy. Circulation 109: 824-827 [Abstract] [Full Text]  
• Kimmelstiel, C. D., Maron, B. J. (2004). Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy. Circulation 109: 452-456 [Full Text]  
• Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H. III, Spirito, P., Ten Cate, F. J., Wigle, E. D., Vogel, R. A., Abrams, J., Bates, E. R., Brodie, B. R., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'rourke, R. A., Pohost, G. M., Schofield, R. S., Tracy, C. M., Winters, W. L. Jr, Klein, W. W., Priori, S. G., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Deckers, J., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A. (2003). American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42: 1687-1713 [Full Text]  
• Writing Committee Members, , Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H. III, Spirito, P., Ten Cate, F. J., Wigle, E. D., ACCF Task Force on Clinical Expert Consensus Docum, , Vogel, R. A., Abrams, J., Bates, E. R., Brodie, B. R., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'Rourke, R. A., Pohost, G. M., Schofield, R. S., Tracy, C. M., Winters, W. L. Jr, ESC Committee for Practice Guidelines Members, , Klein, W. W., Priori, S. G., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Deckers, J., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A. (2003). American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24: 1965-1991 [Full Text]  
• Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., Camici, P. G. (2003). Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy. NEJM 349: 1027-1035 [Abstract] [Full Text]  
• Maron, B. J., Casey, S. A., Hauser, R. G., Aeppli, D. M. (2003). Clinical course of hypertrophiccardiomyopathy with survival to advanced age. J Am Coll Cardiol 42: 882-888 [Abstract] [Full Text]  
• Maron, B. J., Estes, N. A. M. III, Maron, M. S., Almquist, A. K., Link, M. S., Udelson, J. E. (2003). Primary Prevention of Sudden Death as a Novel Treatment Strategy in Hypertrophic Cardiomyopathy. Circulation 107: 2872-2875 [Full Text]  
• (2003). LV Outflow-Tract Obstruction Predicts Poor HCM Prognosis. Journal Watch Cardiology 2003: 4-4 [Full Text]  
• Monserrat, L., Penas-Lado, M., Castro-Beiras, A., Iqbal, K., Tramboo, N. A., Mohi-Ud-Din, K., Spevack, D. M., Maron, M. S., Olivotto, I., Maron, B. J. (2003). Hypertrophic Cardiomyopathy and Outflow Tract Obstruction. NEJM 348: 1815-1816 [Full Text]  
• Malik, I. (2003). JournalScan. Heart 89: 471-472 [Full Text]